Literature DB >> 25112235

Gynaecomastia--pathophysiology, diagnosis and treatment.

Harmeet S Narula1, Harold E Carlson2.   

Abstract

Gynaecomastia (enlargement of the male breast tissue) is a common finding in the general population. Most cases of gynaecomastia are benign and of cosmetic, rather than clinical, importance. However, the condition might cause local pain and tenderness, could occasionally be the result of a serious underlying illness or a medication, or be inherited. Breast cancer in men is much less common than benign gynaecomastia, and the two conditions can usually be distinguished by a careful physical examination. Estrogens are known to stimulate the growth of breast tissue, whereas androgens inhibit it; most cases of gynaecomastia result from deficient androgen action or excessive estrogen action in the breast tissue. In some cases, such as pubertal gynaecomastia, the breast enlargement resolves spontaneously. In other situations, more active treatment might be required to correct an underlying condition (such as hyperthyroidism or a benign Leydig cell tumour of the testis) or medications that could cause breast enlargement (such as spironolactone) might need to be discontinued. For men with hypogonadism, administration of androgens might be helpful, as might antiestrogen therapy in men with endogenous overproduction of estrogens. Surgery to remove the enlarged breast tissue might be necessary when gynaecomastia does not resolve spontaneously or with medical therapy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25112235     DOI: 10.1038/nrendo.2014.139

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN: 1759-5029            Impact factor:   43.330


  183 in total

Review 1.  Adrenocortical carcinoma: past, present, and future.

Authors:  Jennifer Lafemina; Murray F Brennan
Journal:  J Surg Oncol       Date:  2012-04-03       Impact factor: 3.454

2.  Short-term and long-term histologic effects of castration and estrogen treatment on breast tissue of 14 male-to-female transsexuals in comparison with two chemically castrated men.

Authors:  R C Kanhai; J J Hage; P J van Diest; E Bloemena; J W Mulder
Journal:  Am J Surg Pathol       Date:  2000-01       Impact factor: 6.394

Review 3.  Drug-induced gynecomastia.

Authors:  John D Bowman; Hyunah Kim; Juan J Bustamante
Journal:  Pharmacotherapy       Date:  2012-11-16       Impact factor: 4.705

Review 4.  Large-cell calcifying Sertoli cell tumors of the testes in pediatrics.

Authors:  Evgenia Gourgari; Emmanouil Saloustros; Constantine A Stratakis
Journal:  Curr Opin Pediatr       Date:  2012-08       Impact factor: 2.856

5.  Gynecomastia from exposure to vaginal estrogen cream.

Authors:  C V DiRaimondo; A C Roach; C K Meador
Journal:  N Engl J Med       Date:  1980-05-08       Impact factor: 91.245

6.  Hypogonadism and mineralocorticoid excess. The 17-hydroxylase deficiency syndrome.

Authors:  O Goldsmith; D H Solomon; R Horton
Journal:  N Engl J Med       Date:  1967-09-28       Impact factor: 91.245

7.  Gender differences in the regulation of P450 aromatase expression and activity in human adipose tissue.

Authors:  P G McTernan; A Anwar; M C Eggo; A H Barnett; P M Stewart; S Kumar
Journal:  Int J Obes Relat Metab Disord       Date:  2000-07

8.  Leptin enhances, via AP-1, expression of aromatase in the MCF-7 cell line.

Authors:  Stefania Catalano; Stefania Marsico; Cinzia Giordano; Loredana Mauro; Pietro Rizza; Maria Luisa Panno; Sebastiano Andò
Journal:  J Biol Chem       Date:  2003-05-06       Impact factor: 5.157

9.  Male pseudohermaphroditism due to 17 alpha-hydroxylase deficiency.

Authors:  M I New
Journal:  J Clin Invest       Date:  1970-10       Impact factor: 14.808

10.  Treatment of testosterone-induced gynecomastia with the aromatase inhibitor, anastrozole.

Authors:  E L Rhoden; A Morgentaler
Journal:  Int J Impot Res       Date:  2004-02       Impact factor: 2.896

View more
  20 in total

1.  Invasive lobular carcinoma: a rare presentation in the male breast.

Authors:  Elisa Melo Abreu; Pedro Pereira; José Carlos Marques; Gonçalo Esteves
Journal:  BMJ Case Rep       Date:  2016-05-05

2.  Gynaecomastia in two men on stable antiretroviral therapy who commenced treatment for tuberculosis.

Authors:  Jeremy D Kratz; Ahmad Y El-Shazly; Santos G Mambuque; Elpidio Demetria; Peter Veldkamp; Timothy S Anderson
Journal:  Malawi Med J       Date:  2016-12       Impact factor: 0.875

3.  Morphological Features and Immunohistochemical Profiling of Male Breast Gynaecomastia; A Large Tissue Microarray Study.

Authors:  Prakruthi Prasad; Aneliese Bennett; Val Speirs; Abeer M Shaaban
Journal:  Front Oncol       Date:  2022-06-23       Impact factor: 5.738

Review 4.  Effects of hormones and hormone therapy on breast tissue in transgender patients: a concise review.

Authors:  Harsh Patel; Victor Arruarana; Lucille Yao; Xiaojiang Cui; Edward Ray
Journal:  Endocrine       Date:  2020-02-17       Impact factor: 3.633

Review 5.  Gynecomastia and hormones.

Authors:  Andrea Sansone; Francesco Romanelli; Massimiliano Sansone; Andrea Lenzi; Luigi Di Luigi
Journal:  Endocrine       Date:  2016-05-04       Impact factor: 3.633

Review 6.  Diagnosis and Management of Gynecomastia for Urologists.

Authors:  Lee Baumgarten; Ali A Dabaja
Journal:  Curr Urol Rep       Date:  2018-05-17       Impact factor: 3.092

7.  A Prospective Evaluation of Tru-Cut Biopsy and Fine-needle Aspiration Cytology in Male Breast Cancer Detection.

Authors:  Chiara Adriana Pistolese; Tommaso Perretta; Giulia Claroni; Lucia Anemona; Francesca Servadei; Alberto Collura; Michela Censi; Marco Materazzo; Marco Pellicciaro; Feliciana Lamacchia; Gianluca Vanni
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

8.  Gynaecomastia: when and why to refer to specialist care.

Authors:  Hannah L Bromley; Rajiv Dave; Nigel Lord; Paul Wright; Matthew Rowland; Ashu Gandhi
Journal:  Br J Gen Pract       Date:  2021-03-26       Impact factor: 5.386

9.  Expected Reduction of The Nipple-Areolar Complex Over Time After Treatment of Gynecomastia with Ultrasound-Assisted Liposuction Mastectomy Compared to Subcutaneous Mastectomy Alone.

Authors:  Peter P Pfeiler; Rosalia Luketina; Khaled Dastagir; Peter M Vogt; Tobias R Mett; Alexander Kaltenborn; Sören Könneker
Journal:  Aesthetic Plast Surg       Date:  2020-10-27       Impact factor: 2.708

10.  Clinical and ultrasonographic features of male breast tumors: A retrospective analysis.

Authors:  Wei-Hsin Yuan; Anna Fen-Yau Li; Yi-Hong Chou; Hui-Chen Hsu; Ying-Yuan Chen
Journal:  PLoS One       Date:  2018-03-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.